Pelvic floor disorders, in particular pelvic organ prolapse (POP) and stress urinary incontinence (SUI), are common in women. There is a described higher risk to develop postoperative SUI also in preoperatively continent women: this happens because in 30% of women the relief of the urethral obstruction caused by prolapse, unmasks a pre-existing compromised urethral function and thus an "occult" or potential SUI. The aims of this study were to evaluate the role of Macroplastique® implant, TVT-O or surgery alone in the management of occult urinary stress incontinence during prolapse surgery in terms of success rate and adverse events.
We enrolled 47 consecutive patients scheduled to vaginal prolapse surgery who did not report symptoms of stress incontinence. We collected surgical data, success and complication rates. Moreover we compared all the data with retrospective ones regarding surgery plus concomitant TVT-O (39 pts) and surgery alone (41 pts).
At 12-months follow-up, we reported a success rate of 87,2% in the "macroplastique group", comparable to the "surgery plus TVT-O group", with a statistically significant difference in comparison to the "surgery alone" group. "Surgery + TVT-O" group reported a higher rate of major complications (p<0,01) in comparison to the other groups.
Postoperative SUI prevention at the time of prolapse repair remains a challenging issue. In selected patients, Macroplastique may play an interesting role having a good success rate and a low complication rate and for these reasons it may be proposed as A concomitant procedure during POP surgery.
European journal of obstetrics, gynecology, and reproductive biology. 2018 Apr 21 [Epub ahead of print]
Roberto Montera, Giuseppe Scaletta, Francesco Plotti, Salvatore Lopez, Daniela Luvero, Stella Capriglione, Alessia Aloisi, Alessandra Gatti, Carlo De Cicco Nardone, Raffaella Carassiti, Corrado Terranova, Roberto Angioli
Department of Obstetrics and Gynaecology, Campus Bio-Medico, University of Rome, Italy., Department of Obstetrics and Gynaecology, Campus Bio-Medico, University of Rome, Italy. Electronic address: .